Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery …
Over the last 12 months, insiders at Semler Scientific, Inc. have bought $0 and sold $308,389 worth of Semler Scientific, Inc. stock.
On average, over the past 5 years, insiders at Semler Scientific, Inc. have bought $2.15M and sold $2.82M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 26,868 shares for transaction amount of $755,259 was made by SEMLER ERIC (director) on 2023‑09‑13.
2024-08-29 | Sale | CEO | 10,101 0.1497% | $28.34 | $286,302 | -7.09% | ||
2024-08-28 | Sale | CEO | 780 0.0113% | $28.32 | $22,087 | -8.74% | ||
2023-09-13 | director | 26,868 0.3916% | $28.11 | $755,259 | +9.95% | |||
2023-09-12 | director | 25,903 0.372% | $27.70 | $717,513 | +8.70% | |||
2023-09-11 | director | 25,000 0.3631% | $26.98 | $674,500 | +12.84% | |||
2022-02-28 | Sale | Chief Executive Officer | 2,000 0.0294% | $72.65 | $145,291 | -50.36% | ||
2022-02-22 | Sale | Chief Executive Officer | 2,000 0.0297% | $70.22 | $140,430 | -47.49% | ||
2022-02-15 | Sale | Chief Executive Officer | 2,000 0.0291% | $76.04 | $152,079 | -51.87% | ||
2022-02-07 | Sale | Chief Executive Officer | 2,000 0.0296% | $78.73 | $157,451 | -52.22% | ||
2022-02-01 | Sale | Chief Executive Officer | 2,000 0.0288% | $76.53 | $153,056 | -51.47% | ||
2022-01-24 | Sale | Chief Executive Officer | 2,000 0.0284% | $72.35 | $144,696 | -48.78% | ||
2022-01-18 | Sale | Chief Executive Officer | 2,000 0.0294% | $76.69 | $153,374 | -49.50% | ||
2021-10-25 | Sale | Chief Executive Officer | 1,250 0.0185% | $144.03 | $180,036 | -68.58% | ||
2021-10-18 | Sale | Chief Executive Officer | 1,250 0.0184% | $137.36 | $171,704 | -66.92% | ||
2021-10-11 | Sale | Chief Executive Officer | 1,250 0.0186% | $129.01 | $161,258 | -63.74% | ||
2021-10-04 | Sale | Chief Executive Officer | 1,250 0.0185% | $127.28 | $159,099 | -62.85% | ||
2021-09-27 | Sale | Chief Executive Officer | 1,250 0.0179% | $124.89 | $156,110 | -62.69% | ||
2021-09-20 | Sale | Chief Executive Officer | 1,250 0.0182% | $105.79 | $132,236 | -54.08% | ||
2021-09-13 | Sale | Chief Executive Officer | 1,250 0.0188% | $108.52 | $135,647 | -53.10% | ||
2021-09-07 | Sale | Chief Executive Officer | 1,250 0.0185% | $108.97 | $136,209 | -52.96% |
Murphy-Chutorian Douglas | CEO | 26742 0.3824% | $39.90 | 8 | 57 | <0.0001% |
Chang William H | 10 percent owner | 965306 13.8053% | $39.90 | 4 | 0 | <0.0001% |
William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 | 10 percent owner | 412537 5.8999% | $39.90 | 1 | 10 | +268.41% |
SEMLER ERIC | director | 77771 1.1122% | $39.90 | 4 | 0 | |
Collins Aidan Matthew | director | 1100 0.0157% | $39.90 | 2 | 0 | <0.0001% |
Cerity Partners | $20.5M | 9.93 | 701,789 | +0.09% | +$17,701.26 | 0.06 | |
The Vanguard Group | $9.33M | 4.52 | 319,414 | -3.78% | -$366,965.23 | <0.0001 | |
BlackRock | $9.06M | 4.39 | 310,252 | -3.59% | -$337,404.71 | <0.0001 | |
LSV Asset Management | $7.39M | 3.58 | 252,887 | +58.02% | +$2.71M | 0.02 | |
Acadian Asset Management | $4.84M | 2.35 | 165,876 | +68.24% | +$1.96M | 0.02 |